McKesson Ventures, the corporate venture capital arm of healthcare product supplier McKesson Corporation, has appointed Lizzie Lee as its newest senior director.
In her new position, Lee will oversee portfolio development and help foster collaboration between McKesson’s business units, portfolio companies and customers. She will also lead the firm’s market research, including the development of thought leadership content on emerging trends.
Lee joined McKesson in 2017 and was previously a director on its enterprise strategy team. She has a decade of healthcare experience, part of which was spent as a consultant at professional services firm, ZS Associates.
At ZS, Lee helped pharmaceutical companies shape their go-to-market strategy and launch planning activities as well as with market access. She said: “I am passionate about connecting the innovation of novel startups with the power of industry knowledge, market research and experience.
“Joining the McKesson Ventures team is the perfect avenue to move McKesson’s innovation agenda forward and foster the efforts of our portfolio companies.”
McKesson promoted GCV Rising Star Dave Schulte to senior vice-president and head of McKesson Ventures in June 2020. He replaced Tom Rodgers, who was promoted to executive vice-president and chief strategy officer at the company.
Photo of Lizzie Lee courtesy of LinkedIn.